Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations

被引：51

作者：

Haber, D ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Charlestown, MA 02129 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 21期

关键词：

D O I：

10.1056/NEJMed020044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1660 / 1662

页数：3

共 9 条

[1] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[2] Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients [J].

Grann, VR ;

Panageas, KS ;

Whang, W ;

Antman, KH ;

Neugut, AI .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :979-985

[3] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J].

Kauff, ND ;

Satagopan, JM ;

Robson, ME ;

Scheuer, L ;

Hensley, M ;

Hudis, CA ;

Ellis, NA ;

Boyd, J ;

Borgen, PI ;

Barakat, RR ;

Norton, L ;

Offit, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1609-1615

[4] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial [J].

King, MC ;

Wieand, S ;

Hale, K ;

Lee, M ;

Walsh, T ;

Owens, K ;

Tait, J ;

Ford, L ;

Dunn, BK ;

Costantino, J ;

Wickerham, L ;

Wolmark, N ;

Fisher, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18) :2251-2256

[5] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. [J].

Meijers-Heijboer, H ;

van Geel, B ;

van Putten, WLJ ;

Henzen-Logmans, SC ;

Seynaeve, C ;

Menke-Pluymers, MBE ;

Bartels, CCM ;

Verhoog, LC ;

van den Ouweland, AMW ;

Niermeijer, MF ;

Brekelmans, CTM ;

Klijn, JGM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :159-164

[6] Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers [J].

Rebbeck, TR ;

Levin, AM ;

Eisen, A ;

Snyder, C ;

Watson, P ;

Cannon-Albright, L ;

Isaacs, C ;

Olopade, O ;

Garber, JE ;

Godwin, AK ;

Daly, MB ;

Narod, SA ;

Neuhausen, SL ;

Lynch, HT ;

Weber, BL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17) :1475-1479

[7] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J].

Rebbeck, TR ;

Lynch, HT ;

Neuhausen, SL ;

Narod, SA ;

van't Veer, L ;

Garber, JE ;

Evans, G ;

Isaacs, C ;

Daly, MB ;

Matloff, E ;

Olopade, OI ;

Weber, BL .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1616-1622

[8]

Schrag D, 1997, NEW ENGL J MED, V337, P434

[9]

Struewing J P, 1995, J Natl Cancer Inst Monogr, P33

← 1 →